Archive for January, 2008

Gastrointestinal Cancers: Progress with Targeted Therapies

Robert Mayer
Robert Mayer

ROBERT MAYER, Dana-Farber Cancer Institute, Boston
One of the leading participants at the 2008 Gastrointestinal Cancers Symposium, Robert Mayer, gave Peter Goodwin his assessment of some of the emerging new therapies being announced, for colorectal, liver and pancreas cancers.

Liver Cancer: Risk Groups for Screening

Eugene Schiff
Eugene Schiff

REFERENCE: General Session IV
EUGENE SCHIFF, University of Miami
Screening for Hepatitits C and B, and subsequent screening for cancer, can save millions of lives from hepatocellular carcinoma. Eugene Schiff told the Gastrointestinal Cancers Conference in Orlando which populations are most at risk. He discussed his data with Peter Goodwin.

Adjuvant Chemoradiotherapy: Big Gains In Pancreas Cancer

Charles Hsu
Charles Hsu

CHARLES HSU, Johns Hopkins University, Baltimore
Big improvements in overall survival were achieved by combining radiation with adjuvant chemotherapy for patients with pancreas cancer in a dtudy reported to the conference in Orlando. Charles Hsu told Peter Goodwin about their findings from more than 1,000 patients.

How to Prevent Stomach and Esophageal Cancers?

William Blot
William Blot

REFERENCE: General Session 1: Cancers of the Esophagus and Stomach
WILLIAM BLOT, Vanderbilt University, Nashville TN
Obesity emerged as a key cause of esophageal cancer from data presented by William Blot who told Peter Goodwin about the changing pattern of both esophageal and stomach cancer throughout the world, and about the likely ways of preventing them.

London School of Hygiene & Tropical Medicine Audio News - Undernutrirtion Causes a Third of Child Deaths

Zulfiqar Bhutta
Zulfiqar Bhutta

Reference: The Lancet, Maternal and Child Undernutrition Special Series
With one child in three killed by it, childhood and maternal undernutrition are discussed in a special series of articles in the Lancet. Sarah Maxwell spoke with Zulfiqar Bhutta about his group’s massive study, and in particular about the risks of not breastfeeding optimally.

(more…)

Meta-Analysis Proves Statins Help Patients With Diabetes

Colin Baigent
Colin Baigent

REFERENCE: Lancet 371:117 January 11, 2008
COLIN BAIGENT, Oxford University
Statins were found to cut cardiovascular event rates by a fifth among patients with both Type I and Type II diabetes in a meta-analysis of 18 000 patients from Oxford University in England and the University of Sydney in Australia. Peter Goodwin asked the lead UK investigator, Colin Baigent, about the findings and their implications.


Buy + Download Now This Interview

Early Breast Cancer Chemotherapy: Long Term Findings

Richard Peto
Richard Peto

REFERENCE: Lancet 371:29-40; January 5, 2008
RICHARD PETO, Oxford University
The prospect of cutting breast cancer mortality in half throughout the world is held out by Richard Peto of the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). He talks with Peter Goodwin following the group’s most recent publication in The Lancet.

Buy + Download Now This Interview

Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability

Peter Tyrer
Peter Tyrer

REFERENCE: Lancet 371:57 January 5, 2008
PETER TYRER, Imperial College, W6 8RP London
A randomized study comparing treatment with risperidone, or haloperidol, or placebo to treat patients who have intellectual disability presenting with a syndrome commonly labelled as “aggressive challenging behaviour” has shown that the anti-psychotic medicines gave no benefit. Peter Goodwin met up with Professor Peter Tyrer at London’s Imperial College to ask him about the study.


Buy + Download Now This Interview